New approaches to developing antidepressants by enhancing monoaminergic neurotransmission

Author： Bymaster Frank P   McNamara Robert K   Tran Pierre V  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.4, 2003-04, pp. : 531-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1563-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants

By  

Current Neuropharmacology, Vol. 15, Iss. 7, 2017-08 ,pp. : 963-976

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus

By Dremencov E.   Gur E.   Lerer B.   Newman M.E.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 729-739

Elsevier

Access to resources Recommend Favorite

Serotonin 5-HT4 Receptors: A New Strategy for Developing Fast Acting Antidepressants?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3751-3762

Bentham Science Publishers

Access to resources Recommend Favorite